[go: up one dir, main page]

NO20062585L - Steroider med en blandet androgen- og progestagen profil - Google Patents

Steroider med en blandet androgen- og progestagen profil

Info

Publication number
NO20062585L
NO20062585L NO20062585A NO20062585A NO20062585L NO 20062585 L NO20062585 L NO 20062585L NO 20062585 A NO20062585 A NO 20062585A NO 20062585 A NO20062585 A NO 20062585A NO 20062585 L NO20062585 L NO 20062585L
Authority
NO
Norway
Prior art keywords
progestagen
profile
steroids
androgen
mixed
Prior art date
Application number
NO20062585A
Other languages
English (en)
Inventor
Dirk Leysen
Marcel Everet De Gooijer
Arij Jan Grootenhuis
Jaap Van Der Louw
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20062585L publication Critical patent/NO20062585L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer 19-nor-D-homosteroider, som har en blandet androgen/progestagen-profil, som er oralt aktiv, forhindrer trabekulær benmineraltetthets- (BMD) tap, og som ikke har levertoksisitet, som har en struktur i henhold til formel I: hvor R1 er O, eller NOR, der R er hydrogen, (Ci-6)alkyl eller (Ci-6)acyl, R2 er metyl eller etyl, og R3 er hydrogen eller (Ci-i5)acyl.
NO20062585A 2003-12-22 2006-06-06 Steroider med en blandet androgen- og progestagen profil NO20062585L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104898 2003-12-22
PCT/EP2004/053475 WO2005061528A2 (en) 2003-12-22 2004-12-15 Steroids having a mixed androgenic and progestagenic profile

Publications (1)

Publication Number Publication Date
NO20062585L true NO20062585L (no) 2006-09-20

Family

ID=34707282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062585A NO20062585L (no) 2003-12-22 2006-06-06 Steroider med en blandet androgen- og progestagen profil

Country Status (30)

Country Link
US (1) US7582622B2 (no)
EP (1) EP1720895B1 (no)
JP (1) JP2007515455A (no)
KR (1) KR20060123484A (no)
CN (1) CN1898258B (no)
AR (1) AR046966A1 (no)
AT (1) ATE373674T1 (no)
AU (1) AU2004303524A1 (no)
BR (1) BRPI0417781A (no)
CA (1) CA2549148A1 (no)
CY (1) CY1106935T1 (no)
DE (1) DE602004009107T2 (no)
DK (1) DK1720895T3 (no)
EC (1) ECSP066666A (no)
ES (1) ES2294569T3 (no)
HR (1) HRP20070492T3 (no)
IL (1) IL175890A0 (no)
IS (1) IS8488A (no)
MX (1) MXPA06007195A (no)
NO (1) NO20062585L (no)
NZ (1) NZ547772A (no)
PE (1) PE20050677A1 (no)
PL (1) PL1720895T3 (no)
PT (1) PT1720895E (no)
RU (1) RU2357972C2 (no)
SI (1) SI1720895T1 (no)
TW (1) TW200521134A (no)
UA (1) UA84037C2 (no)
WO (1) WO2005061528A2 (no)
ZA (1) ZA200604976B (no)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
FR1434172A (fr) 1963-12-24 1966-04-08 Ciba Geigy Procédé de préparation de nouvelles oestrones substituées
NL125071C (no) 1963-12-24
US3952322A (en) * 1971-09-30 1976-04-20 Lester Wolfe Photographic lighting system
US4412993A (en) * 1980-01-25 1983-11-01 The Upjohn Company Method of treating pseudopregnancy, galactorrhea and mastitis in mammals
US4788218A (en) * 1984-05-21 1988-11-29 Sri International 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses
FI860253A0 (fi) * 1984-05-21 1986-01-20 Stanford Res Inst Int 17 -hydroxi-7 -metyl-d-homo -19-norandrost-4,16-dien-3-on och dess 17 -estrar och foerfarande foer framstaellning av dessa foereningar.
SK282796B6 (sk) 1998-06-19 2002-12-03 Akzo Nobel N.V. Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom
US6881728B1 (en) 1999-03-08 2005-04-19 Akzo Nobel N.V. 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
US6756366B1 (en) 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
TW548277B (en) 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens

Also Published As

Publication number Publication date
RU2357972C2 (ru) 2009-06-10
KR20060123484A (ko) 2006-12-01
DE602004009107D1 (de) 2007-10-31
WO2005061528A2 (en) 2005-07-07
ES2294569T3 (es) 2008-04-01
CN1898258A (zh) 2007-01-17
EP1720895A2 (en) 2006-11-15
US20070155836A1 (en) 2007-07-05
CY1106935T1 (el) 2012-09-26
DE602004009107T2 (de) 2008-06-19
CN1898258B (zh) 2010-06-16
US7582622B2 (en) 2009-09-01
MXPA06007195A (es) 2006-09-04
SI1720895T1 (sl) 2007-12-31
UA84037C2 (ru) 2008-09-10
NZ547772A (en) 2009-01-31
PE20050677A1 (es) 2005-10-04
HRP20070492T3 (hr) 2007-12-31
WO2005061528A3 (en) 2005-09-09
JP2007515455A (ja) 2007-06-14
ZA200604976B (en) 2007-04-25
AU2004303524A1 (en) 2005-07-07
BRPI0417781A (pt) 2007-03-20
DK1720895T3 (da) 2008-01-14
TW200521134A (en) 2005-07-01
IS8488A (is) 2006-05-26
EP1720895B1 (en) 2007-09-19
ECSP066666A (es) 2006-10-25
RU2006126632A (ru) 2008-01-27
CA2549148A1 (en) 2005-07-07
ATE373674T1 (de) 2007-10-15
PL1720895T3 (pl) 2008-02-29
PT1720895E (pt) 2007-10-09
AR046966A1 (es) 2006-01-04
IL175890A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
NO20050870L (no) Fosfodiesterase 4-inhibitorer, inkludert N-substituerte anilin- og difenylaminanaloger
HRP20090195T1 (hr) Inhibitori mitotičkih kinezina
GB0505048D0 (en) Compounds with PGD antagonist activity
DK1653947T3 (da) (Hydroxyphenyl)-1H-indol-3-carbaldehydoximderivater som östrogenmidler
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
NO20062031L (no) Derivater av N-[fenyl(alkylptpertdtn-2-yl)metyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske media
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
WO2008090066A3 (en) Stabilization of uv-sensitive active ingredients
NZ516525A (en) Orally active androgens
CO5680437A2 (es) Derivados de pirazol-e- imidazo-pirimidina
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
TW200640916A (en) (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, their preparation and their application in therapeutics
EP1655291A4 (en) COMPOUNDS WITH THROMBOPOIETIN RECEPTOR AGONISM
NO20062585L (no) Steroider med en blandet androgen- og progestagen profil
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
SI1450750T1 (sl) Derivati 2-amino-4-piridilmetil-tiazolina in njihova uporaba kot inhibitorji inducibilne NO-sintaze
NO20041671L (no) Anthelmintic composition
DK1163258T3 (da) Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
AU5209600A (en) Orally active androgens
DK1584617T3 (da) Alkylpyridiniumdicyanamider som polære opløsningsmidler
MXPA05007502A (es) Antagonistas de receptor de androgeno.
TW200603812A (en) D-homo-17-chlor-16(17)-ene steroids

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application